Inventor · disambiguated record
Saswata Lahiri
Also filed as: LAHIRI SASWATA
26 granted patents·9 pending applications·54 citations·filing 1999–2021
93Inventor score
Files withFRESENIUS KABI ONCOLOGY LTD19LUPIN LAB LTD4FRESENIUS KABI IPSUM S R L3KNOLLER HELMUT3FRESENIUS KABI DE GMBH1
Top patents by PatentIndex Score
35 records- 0191US9440979B2Process for the preparation of pralatrexateFRESENIUS KABI ONCOLOGY LTD·Filed 2013·Granted Sep 13, 2016·25 cites·25 claims
- 0284US10414830B2Crystalline forms of per-chloro-γ-cyclodextrinesFRESENIUS KABI IPSUM S R L·Filed 2016·Granted Sep 17, 2019·2 cites·11 claims
- 0382US10800763B2Polymorphic forms of Afatinib free base and Afatinib dimaleateFRESENIUS KABI ONCOLOGY LTD·Filed 2016·Granted Oct 13, 2020·3 cites·21 claims
- 0482US10414829B2Process for the preparation of sugammadex and its intermediatesFRESENIUS KABI IPSUM S R L·Filed 2016·Granted Sep 17, 2019·2 cites·12 claims
- 0579US11098037B2Process for preparing alectinib or a pharmaceutically acceptable salt thereofFRESENIUS KABI ONCOLOGY LTD·Filed 2018·Granted Aug 24, 2021·1 cites·9 claims
- 0677US10577433B2Process for the preparation of sugammadexFRESENIUS KABI IPSUM S R L·Filed 2017·Granted Mar 3, 2020·1 cites·17 claims
- 0777US8901322B2Crystalline forms of cabazitaxel and process for preparation thereofFRESENIUS KABI ONCOLOGY LTD·Filed 2012·Granted Dec 2, 2014·7 cites·30 claims
- 0874US11465999B2Process for preparing Alectinib or a pharmaceutically acceptable salt thereofFRESENIUS KABI ONCOLOGY LTD·Filed 2021·Granted Oct 11, 2022·0 cites·23 claims
- 0973US8524893B2Process for the preparation of temsirolimus and its intermediatesGUPTA NITIN·Filed 2011·Granted Sep 3, 2013·2 cites·29 claims
- 1072US9199953B2Amorphous form of cabazitaxel and process for its preparationFRESENIUS KABI ONCOLOGY LTD·Filed 2012·Granted Dec 1, 2015·2 cites·7 claims
- 1168US10544109B2Process for the preparation of xylene linked cyclam compoundsFRESENIUS KABI ONCOLOGY LTD·Filed 2016·Granted Jan 28, 2020·1 cites·15 claims
- 1268US7078532B2Process for manufacture of fosinopril sodiumLUPIN LAB LTD·Filed 2001·Granted Jul 18, 2006·5 cites·30 claims
- 1367US11739057B2Polymorphic forms of Belinostat and processes for preparation thereofFRESENIUS KABI ONCOLOGY LTD·Filed 2021·Granted Aug 29, 2023·0 cites·20 claims
- 1463US9000193B2Process for the preparation of cabazitaxelFRESENIUS KABI ONCOLOGY LTD·Filed 2014·Granted Apr 7, 2015·0 cites·2 claims
- 1562US11390612B2Polymorphic forms of Afatinib free base and Afatinib dimaleateFRESENIUS KABI ONCOLOGY LTD·Filed 2020·Granted Jul 19, 2022·0 cites·17 claims
- 1661US9643932B2Process for the preparation of bendamustine hydrochlorideFRESENIUS KABI ONCOLOGY LTD·Filed 2014·Granted May 9, 2017·0 cites·11 claims
- 1759US11059777B2Polymorphic forms of belinostat and processes for preparation thereofFRESENIUS KABI ONCOLOGY LTD·Filed 2017·Granted Jul 13, 2021·0 cites·9 claims
- 1855US8901327B2Process for the preparation cabazitaxelFRESENIUS KABI ONCOLOGY LTD·Filed 2012·Granted Dec 2, 2014·0 cites·30 claims
- 1953US9108924B2Process for the preparation of bendamustine hydrochlorideFRESENIUS KABI ONCOLOGY LTD·Filed 2012·Granted Aug 18, 2015·0 cites·27 claims
- 2052US2006063939A1Process for manufacture of fosinopril sodiumLUPIN LAB LTD·Filed 2005·Application pending·0 cites
- 2151US2006160772A1Process for manufacture of fosinopril sodiumLUPIN LAB LTD·Filed 2005·Application pending·0 cites
- 2251US2023174444A1Process for the preparation of propofolFRESENIUS KABI ONCOLOGY LTD·Filed 2021·Application pending·0 cites
- 2349US8513427B2Compounds for producing substituted sulfoxides, process for producing the same and use thereofLAHIRI SASWATA·Filed 2009·Granted Aug 20, 2013·0 cites·34 claims
- 2449US2014088298A9Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparationKNOLLER HELMUT·Filed 2011·Application pending·0 cites
- 2547US2006122401A1Process for manufacture of fosinopril sodiumLUPIN LAB LTD·Filed 2005·Application pending·0 cites
- 2647US2014073779A9Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparationKNOLLER HELMUT·Filed 2011·Application pending·0 cites
- 2745US2013231486A1Compounds for producing substituted sulfoxides, process for producing the same and use thereofMATRIX LAB LTD·Filed 2013·Application pending·0 cites
- 2844US11078231B2Process for purification of carfilzomib intermediateFRESENIUS KABI ONCOLOGY LTD·Filed 2017·Granted Aug 3, 2021·0 cites·13 claims
- 2943US11667654B2Process for the preparation of boronic acid estersFRESENIUS KABI ONCOLOGY LTD·Filed 2018·Granted Jun 6, 2023·0 cites·18 claims
- 3043US10253066B2Process for purification of CarfilzomibFRESENIUS KABI ONCOLOGY LTD·Filed 2015·Granted Apr 9, 2019·0 cites·13 claims
- 3139US11440912B2Process for the preparation of ribociclib and its saltsFRESENIUS KABI ONCOLOGY LTD·Filed 2018·Granted Sep 13, 2022·0 cites·11 claims
- 3239US2013217871A1Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparationKNOLLER HELMUT·Filed 2011·Application pending·0 cites
- 3338US6717007B1Regiospecific synthesis of phosphonous acidsLUPIN LTD·Filed 1999·Granted Apr 6, 2004·3 cites·9 claims
- 3438US2015297738A1Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparationFRESENIUS KABI DE GMBH·Filed 2015·Application pending·0 cites
- 3536US8304578B2Process for producing 1-[2-(dimethylamino)-1-(4-phenol)ethyl]cyclohexanolTYAGI OM DUTT·Filed 2008·Granted Nov 6, 2012·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Saswata Lahiri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →